PS-012-Validation of histologic and non-invasive measures of fibrosis as surrogate end points of disease progression in patients with primary sclerosing cholangitis

Christopher Bowlus; Mitchell Shiffman; Harry Janssen; Aldo J Montano-Loza; Stephen Caldwell; Velimir Luketic; Xiaomin Lu; Gerald Crans; Chuhan Chung; Mani Subramanian; Robert Myers; Michael P. Manns; Cynthia Levy; Michael Trauner; Zachary Goodman; Andrew Muir

doi:10.1016/S0618-8278(19)30018-0

Back

PS-012-Validation of histologic and non-invasive measures of fibrosis as surrogate end points of disease progression in patients with primary sclerosing cholangitis

Journal article

Peer reviewed

PS-012-Validation of histologic and non-invasive measures of fibrosis as surrogate end points of disease progression in patients with primary sclerosing cholangitis

Christopher Bowlus, Mitchell Shiffman, Harry Janssen, Aldo J Montano-Loza, Stephen Caldwell, Velimir Luketic, Xiaomin Lu, Gerald Crans, Chuhan Chung, Mani Subramanian, …

Journal of hepatology, Vol.70(1), pp.e10-e11

04/2019

DOI: https://doi.org/10.1016/S0618-8278(19)30018-0

Metrics

1 Record Views

Details

Title: PS-012-Validation of histologic and non-invasive measures of fibrosis as surrogate end points of disease progression in patients with primary sclerosing cholangitis
Creators: Christopher Bowlus
Mitchell Shiffman
Harry Janssen
Aldo J Montano-Loza
Stephen Caldwell
Velimir Luketic
Xiaomin Lu
Gerald Crans
Chuhan Chung
Mani Subramanian
Robert Myers
Michael P. Manns
Cynthia Levy
Michael Trauner
Zachary Goodman
Andrew Muir
Publication Details: Journal of hepatology, Vol.70(1), pp.e10-e11
Identifiers: 991006030524602656
Academic Unit: Internal Medicine
Language: English
Resource Type: Journal article

PS-012-Validation of histologic and non-invasive measures of fibrosis as surrogate end points of disease progression in patients with primary sclerosing cholangitis

Related links

Metrics

Details